Austrian Epigenome Editing Startup Epitome Therapeutics Raises €4 Million in Pre-Seed Round
Epitome Therapeutics, an Austrian BioTech startup focused on precision epigenome editing, secured €4 million in pre-seed funding led by XISTA Science Ventures and Caesar Ventures. The funding includes €2 million in equity and €2 million in non-dilutive grants. The company aims to develop its CADENCE platform for programmable gene expression and advance its first drug candidate.